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ABSTRACT Exposure of C3H IOTl/2 Cl 8 cells, synchro-
nized by release from confluence-induced arrest of proliferation,
to different concentrations of N-methyl-N'-nitro-N-nitroso-
guanidine (MNNG) for 30 min at various points during the cell
cycle causes dose-dependent toxicity (decrease in relative col-
ony-forming efficiency or "survival") that increases linearly
during the first GI phase, reaches a maximum in early to middle
S phase, and decreases during late S. In the course of the second
S phase, toxicity again becomes maximal. The transformation
rate (type III foci) increases and decreases with a similar pat-
tern, increasing during the first GI phase to a maximum during
early S phase, subsequently decreasing, and then increasing
again during the second S phase. Although periods of maximal
toxicity and transformation roughly coincide with some portion
of the S phase, the mechanisms underlying these phenomena
appear to differ for the following reasons: (a) toxicity is linearly
related to dose of MNNG, whereas the latter is linearly related
to the logarithm of transformation rate, and (b) the ratio be-
tween toxicity and transformation varies with the cycle phase
and the dose of MNNG.
The relationship between cell proliferation and chemical car-
cinogenesis has been demonstrated in a number of in vvo (1,
2) and in vitro (3-7) studies. Although it is widely recognized
that the proliferation of target cells directly influences the
frequency of neoplastic transformation, the phase or phases of
the cell cycle most susceptible to induction of transformation
by various carcinogenic chemicals has not been established.
Knowledge of the critical biochemical events that take place
in the different phases of the cell's life cycle is increasing, and
the demonstration that cells are particularly sensitive during
one or more phases may help to identify the underlying bio-
chemical mechanisms involved in the initiation and expression
of neoplasia.
Because a firm understanding of intracyclic susceptibility
to neoplastic transformation is important, we have examined
the effect of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)
applied for brief intervals at precise points in the cycle of
1OT1/2 cells synchronized by release from confluence-induced
arrest of proliferation. We have used procedures that allow both
toxicity and transformation to be quantitated accurately and
we have used doses of MNNG that produce toxicity that se-
lectively affects 20-90% of the cell population. MNNG was
chosen because it is a spontaneously activated, rapidly catab-
olized alkylating agent whose pattern of alkylation of DNA
bases is well known (8). Synchronization by release from con-
fluence-induced arrest of proliferation was used because it
appears to cause less disturbance of cellular physiology than do
other synchronization techniques (3, 9), including thymidine
blockade (10, 11) and isoleucine starvation (10, 12). The results
of this study indicate that the S phase of 10T1/2 cells is the
period of maximal sensitivity to MNNG-induced transforma-
tion and toxicity; early S is more sensitive than late S.
MATERIALS AND METHODS
Culture and Synchronization of Cells. C3H 10T1/2 Cl 8
cells were a gift from John B. Little (Harvard University, Bos-
ton, MA). Cells were used when they were between passages
16 and 19 in vitro. At the time they were used, the stock cells
met all basal cytologic and growth criteria established by
Reznikoff et al. (13). Stock cultures were maintained as de-
scribed (14). Spontaneous transformation occurred at the rate
of 39.4 + 2.0/106 cells in the untreated population under the
conditions of culture used in this study. Basal colony-forming
efficiency (mean + SD) was 28.5 + 4.6% (n = 9). Synchroni-
zation of proliferation of cultured cells was accomplished by
plating logarithmic phase cells at a concentration of 106 cells
per 100-mm dish and maintaining them for 4 days without
refeeding; at the end of this time, they had been in a fully
confluent, nonproliferating state for 24 hr. Cultures were then
trypsinized and the dispersed cells were counted and replated
in complete medium, after which they began to proliferate
synchronously (14).
Assessment of Synchronous Proliferation. To monitor the
progression of 1OT1/2 cells through the cell cycle after release
from confluence-induced arrest of proliferation, cells were
counted and the incorporation of [3H]thymidine intoDNA was
determined. For the latter purpose, cultures were exposed to
medium containing 2 MCi (1 Ci = 3.7 X 1010 becquerels) of
[3H]dThd per ml for 30 min. At each time point, triplicate
cultures were exhaustively washed with Hanks' balanced salt
solution and treated with trypsin. Released cells were counted
and lysed in scintillation fluid and the radioactivity was de-
termined in a liquid scintillation spectrometer. The [3H]dThd
incorporated was expressed as cpm/105 cells. The fraction of
cells in S phase was determined by evaluating autoradiograms
prepared with liquid emulsion.
Preparation of MNNG Solutions. MNNG was obtained
from Aldrich. For all experiments, a single stock MNNG solu-
tion was prepared in advance by dissolving the chemical in
spectrophotometric grade acetone (Aldrich). Aliquots were
placed in individual test tubes and the acetone was evaporated
under a stream of N2 gas. The tubes were sealed and kept in a
desiccator at -700C until needed. This procedure was used to
minimize errors in weighing and diluting from experiment to
experiment. Immediately prior to its use, a freshly thawed al-
iquot of MNNG was redissolved in spectrophotometric grade
acetone and appropriately diluted in Hanks' balanced salt so-
lution to the desired concentration. For exposure of cultures,
the medium was removed and replaced with 5 ml of Hanks'
balanced salt solution containing MNNG. All exposures were
Abbreviations: MNNG, N-methyl-N'-nitro-N-nitrosoguanidine;
RCFE, relative colony-forming efficiency.
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for 30 min, after which the balanced salt solution containing
MNNG was removed, and the cultures were washed with bal-
anced salt solution lacking MNNG and re-fed with complete
medium.
Toxicity Assay. To determine toxicity, 500 cells were plated
in 100-mm dishes and relative colony-forming efficiency
(RCFE) was tabulated as described (14). Cultures were fed with
complete medium twice weekly and maintained for 10-14
days. Triplicate cultures were treated at multiple time points
after release from confluence-induced arrest of proliferation.
At each time point, replicate cultures were also exposed to at
least three concentrations of MNNG between 0.5 and 5 gg/ml.
RCFE was also assessed at each time point in cultures exposed
only to Hanks' balanced salt solution (lacking either acetone or
MNNG) or to Hanks' balanced salt solution containing acetone
at the concentration in MNNG-treated cultures.
Transformation Assay. The transformation frequency was
determined by quantitating type III foci (15). Three concen-
trations of MNNG were used at each time point: low dose (re-
duction of RCFE by 15-25%), median dose (reduction of RCFE
by 30-60%), and high dose (reduction of RCFE by 75-95%).
The final concentrations of MNNG (in ,ug/ml Hanks' balanced
salt solution) needed to obtain these levels of toxicity were de-
termined from dose-response curves constructed from data
derived from previous toxicity determinations. In all instances,
the toxicity of the selected dose was reevaluated simultaneously
with the transformation assay so that the exact reduction of the
exposed population by each dose used for transformation studies
could be quantified. Equitoxic doses were used in transfor-
mation studies for each time point during the cell cycle in each
dose range.
For transformation assays, the densities at which cells were
seeded were chosen to ensure that the number of viable cells
per dish remaining after treatment with various concentrations
of MNNG would be approximately equivalent. Plating densities
used were as follows: controls (without or with acetone), 1 X 104
cells; low dose, 1.25 X 104 cells; median dose, 2 X 104 cells; high
dose, 1 X 105 cells. At the time of exposure to MNNG, two plates
at each dose and time were trypsinized and the cells were
counted to verify cell density. In separate studies, we have
found that neither the rate of toxicity nor of transformation was
affected by the initial cell density when 1OT1/2 cells within this
range of plating densities were exposed to MNNG.
All cultures were maintained for 5 weeks after treatment;
they were fed with complete medium twice weekly during this
interval. On day 35, cultures were fixed with methanol/acetic
acid, 3:1 (vol/vol), and stained with Giemsa stain, and the
number of type III foci was determined (14, 15). For each time
point, 10 replicate plates were evaluated for controls (5 with
and 5 without acetone) and for each concentration of MNNG
used. The number of type III foci found ranged from a low of
0-2 per 10 plates in control cultures to a high of 18-23 per 10
plates in cultures treated with median and high concentrations
of MNNG at the times of maximal cell cycle sensitivity to
transformation (26 and 28 hr).
Statistical Analyses. In each treatment group the frequency
distribution of number of foci per plate was compared to a
Poisson distribution. Although a Poisson distribution did not
provide statistically satisfactory fits for the number of foci per
plate, the extent of variation in these data was substantially less
than would have been expected under a Poisson distribution,
rather than more. In this regard, the variance for certain
combined sets of distributions with similar means ranged from
approximately 25% of the mean to approximately 50% of the
mean, when the mean was larger than 1.0.
At all time points and doses, the SDs of rates of toxicity and
transformation were less than 18% of the mean; SDs are not
plotted, other than in Fig. 3, to avoid complicating the
graphs.
RESULTS
Synchronous Cell Proliferation. When released from con-
fluence-induced arrest of proliferation, the cells began to enter
S phase 18-20 hr later (Fig. 1A). About 17 hr were needed for
all cells to complete S phase. The peak rate of DNA synthesis
occurred 9-10 hr after the onset of S. when autoradiographic
evaluation showed that 90-96% of the cell population was in
S phase. These data demonstrated that the majority of cells
replicated their DNA during the S phase and that they entered
the S phase at an average rate of about 10% to 12%/hr. The
doubling of the cell population between 32 and 38 hr after re-
lease indicated that M phase occurred during this interval. This
degree of synchronization, while not perfect, compares favor-
ably with reports in which the extent of synchronization has
been quantitated by other methods (16). Rate of entry of cells
into S phase appears to provide as accurate an assessment of the
degree of synchronization as do other methods.
Toxicity. The cytotoxicity of MNNG was evaluated by de-
termining the RCFE in studies in which several concentrations
of MNNG were applied to replicate cultures for 30 min at
different times after release of cells from confluence-induced
arrest of proliferation (Fig. 2). When exposed to MNNG shortly
after release, the toxicity curve had a distinct shoulder. When
cell populations were exposed to MNNG at later points in the
cycle, the shoulder narrowed and the slope of the curve in-
creased. After reaching a low point at 26-30 hr after reversal,
the RCFE increased and then declined again as the second cycle
reached its S phase (44 hr after release). At the concentrations
used in this study, MNNG does not kill 1OT1/2 cells acutely.
Instead, it makes 1OTI/2 cells reproductively incompetent
(sterile); affected cells remain attached to the dish and they are
viable as indicated by their ability to exclude trypan blue, al-
though they are unable to proliferate.
Cell cycle effects on toxicity are clearly demonstrated in Fig.
1B which shows that the cycle-dependent toxicity pattern is
similar at all three concentrations of MNNG. Toxicity, as in-
dicated by a decrease in the RCFE, steadily increased during
G1 to reach a maximum during early S phase. In the course of
the remainder of the first S phase, toxicity decreased (survival
increased) and then increased to a second maximum in the
second S phase. Basal levels of toxicity were not attained be-
tween the first and second cycles, probably because the second
G1 phase was greatly compressed. Specific toxicity (cells sur-
viving per 106 cells treated per ,tg of MNNG) was nearly
identical at low, median, and high doses. This indicated that
dose and toxicity were linearly related throughout the range
of concentrations of MNNG studied (Fig. 3).
Transformation. At low and median doses of MNNG, the
specific transformation rates of treated cells (cells trans-
formed/106 cells treated/bg MNNG) were similar (Fig. 1C).
Unlike toxicity, the rate of transformation increased only
slightly during the GI phase. The specific transformation rate
of the treated population increased sharply with the onset of
S phase and peaked at 26 and 44 hr after release for cells treated
with low and median doses of MNNG. Transformation de-
creased markedly during the latter half of the S phase. At high
doses of MNNG, the expression of transformation in the treated
population was low during all phases of the cell cycle. High
doses of MNNG transformed only a small fraction of the initial
population because high toxicity prevented the expression of
transformation in many initiated cells. The ratio of rates of
toxicity and transformation in the treated population was
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FIG. 2. Multiple-point dose-toxicity curves for 1OT1/2 cells
treated for 30 min with varying doses of MNNG at different times
after release from confluence-induced arrest of proliferation. Numbers
at the ends of the lines indicate the time (hours) after release when
toxicity was tested. Solid lines indicate the first cycle and broken lines
indicate the second cycle of proliferation. Toxicity is indicated by
decreased RCFE.
When corrected for cell survival, these data provide an as-
sessment of the relative risk to transformation among the
population of cells surviving toxic reactions. The results (Fig.
ID) indicated that the risk to survivors was relatively greater
at higher doses of MNNG-i.e., the relationship between dose
and transformation of survivors was not arithmetically linear.
This is corroborated by Fig. 3, which demonstrates that the dose
of MNNG was directly related to the logarithm of the trans-
formation rate of surviving cells. Although Fig. 3 portrays data
for a single time point, 18 hr after release of confluence-arrest,
the logarithm of the rate of transformation was also linearly
related to dose of MNNG at other time points. The risk of
transformation of surviving cells was greatest during the first
FIG. 1. Cycle-dependent events in 1OT1/2 cells whose prolifer-
ation was synchronized by release from confluence-induced arrest of
proliferation. (A) Timing of DNA synthesis and cell doubling. (B)
Fraction of surviving'cells (no. X 10-4/106 treated) per ug ofMNNG
after exposure for 30 min to low, median, or high dose ofMNNG at
different times after release. (C) Transformation frequency (no./106
treated) of the exposed population perjug ofMNNG after exposure
for 30 min to low, median, or high dose ofMNNG at different times
after release. (D) Transformation frequency (no./106 survivors) of the
surviving population of cells per ,ug ofMNNG after exposure for 30
min to low, median, or high dose ofMNNG at different times after
release. For B, C, and D; 0-0, low dose; O-.-O, median dose;
3 --- 0, high dose.
similar at both low and median doses of MNNG. Throughout
the cycle 2461 + 360 cells (mean + SD) were sterilized and
prevented from proliferating for every cell that was trans-
formed at low doses, and this value was 2358 + 429 at median
doses, but it was 17,269 ± 1277 at high doses. These data suggest
that many potentially transformed cells are prevented from
expressing this property because they cannot proliferate. At
high doses of MNNG, cell sterilization (inability to proliferate)


































FIG. 3. Dose-response curves for cell killing and transformation
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half of S phase and declined during the latter half of this pe-
riod.
DISCUSSION
Several studies of the intracycle sensitivity of cultured cells to
a few carcinogens have been described. Bertram and Heidel-
berger (3) reported the effect of MNNG on 1OT1/2 cells syn-
chronized by release from confluence-induced arrest of pro-
liferation, arrest following growth in the absence of isoleucine
or arginine, and arrest in the presence of high levels of thymi-
dine. They found that the period of maximal sensitivity varied
somewhat with the method of synchronization, but a period of
about 4 hr preceding the G1-S border had the greatest sensi-
tivity in most studies. Unfortunately, interpretation of these
results is hampered by Bertram and Heidelberger's decision to
quantitate both toxicity and transformation in the same plate.
Accurate quantitation of transformation requires that large
numbers of cells per plate be exposed to carcinogen because
transformation occurs at a low frequency. To yield an accu-
rately quantifiable number of discrete colonies for toxicity as-
says, small numbers of cells per plate need to be exposed. In
order to quantify toxicity at the high plating levels required to
measure transformation, Bertram and Heidelberger used a
single dose of MNNG that killed more than 99.9% of the treated
cell population. Furthermore, their use of only one concen-
tration of carcinogen did not allow the frequency of toxicity
and transformation to be compared at multiple doses which
may yield differing proportions of toxicity and transforma-
tion.
Marquardt (4) reported that the middle of S phase showed
the most sensitivity to transformation by both MNNG and
7,12-dimethylbenz[a]anthracene-5,6-oxide in murine M-2 cells
-synchronized by release from thymidine blockade. Both early
S phase (G1-S) and late S phase were less sensitive to the in-
duction of transformation, suggesting that susceptibility to
transformation may be related to the magnitude of DNA syn-
thesis. Exposure to multiple levels of carcinogens was used to
evaluate toxicity and transformation, showing that both effects
were dose-related. However, toxicity, which was maintained
at below 50%, was cycle-independent, indicating that the
transformation frequency was not directly influenced by the
level of cytotoxicity. Furthermore, use of thymidine blockade
did not allow comprehensive examination of the relative sus-
ceptibility of the Gi phase of the cycle.
Jones et al. (5, 6) analyzed the cycle phase susceptibility to
5-fluoro-2'-deoxyuridine, 5-fluorouracil, and 1-(3-D-arabino-
furanosylcytosine of 1OT1/2 cells synchronized by release from
arrest of proliferation induced by growth to confluence or by
growth in isoleucine-deficient medium. They found that the
S phase was the period of greatest sensitivity to all three agents
and that early S appeared to be more susceptible than late S.
Toxicity was also maximal during S phase, but high levels of
transformation occurred when toxicity was less than 50%. These
studies suggest that S phase itself may be characterized by
varying susceptibility to chemical carcinogens. Similarly,
Tsutsui et al. (7) demonstrated that early S phase is most sus-
ceptible to the induction of transformation by the combined
incorporation of BrdUrd during S phase and subsequent irra-
diation with near-ultraviolet light. In that study, early-passage
Syrian hamster embryo cells were synchronized by culture in
a medium containing a low concentration of serum and hy-
droxyurea.
That the S phase is most susceptible to the actions of 1-
f3-D-arabinofuroanosylcytosine, BrdUrd, fluoro-2'-deoxyuri-
dine, and 5-fluorouracil is not surprising because their effects
are predicated upon their incorporation into DNA or upon their
ability to inhibit the production of precursors required for the
synthesis of DNA. MNNG, however, alkylates DNA equiva-
lently during all phases of the cell cycle. Differences in methods
used in the two previous studies that examined the effect of
MNNG on toxicity and transformation in synchronized cells
in vitro may have caused disagreement on the pattern of cycle
phase sensitivity of both toxicity and transformation.
In their pioneering study, Bertram and Heidelberger (3)
applied a single concentration of MNNG that allowed the
survival of less than 0.1% of the exposed population of cells at
all times during the cycle. Furthermore, maximal transfor-
mation frequency occurred at times of minimal toxicity, raising
the possibility that periods of increased transformation were
determined simply by a higher proportion of surviving cells and
not by increased intracyclic sensitivity to transformation. Our
data support this possibility by indicating that cell inactivation
prevents the expression of many potentially transformed cells.
At the high concentrations of MNNG used by Bertram and
Heidelberger (3), our study shows that cell sterilization vastly
predominates over transformation. This fact makes the ap-
parent rate of transformation found at high doses depend
greatly on the numbers of cells that survive in a condition al-
lowing them to proliferate.
Although Marquardt (4) used MNNG doses that killed less
than 50% of the treated population, he used a synchronization
technique (thymidine-induced arrest of proliferation) that is
toxic for cells and that prevents evaluation of the G1 phase of
the cell cycle (11).
Our study supplements and extends these previous reports
by providing information about the effect of varying doses of
MNNG on cycle dependency of toxicity and transformation
in 10T1/2 cells. The results demonstrate clearly that both tox-
icity and transformation in synchronized 1OT1/2 cells are
maximal when these cells are treated during S phase. During
the G1 phase, toxicity and, to a lesser extent, transformation
increase as the time of exposure to equal doses of MNNG ap-
proaches the beginning of S phase. Because alkylation of DNA
is equivalent during all phases of the cycle, this observation
suggests that lesions created during G1 can be partially repaired
before S phase is reached.
In a separate study we measured the removal of selected al-
kylation products from DNA of synchronized 10T1/2 cells (17).
This study demonstrated decisively that N7-methylguanine and
O6-methylguanine residues were excised from DNA during the
G1 phase of the cell cycle but not during the S phase. Thus,
when 1OT1/2 cells commence the replication of DNA during
S phase, neither of these alkylated bases is removed from DNA
until S phase is completed. The present studies suggest that
toxicity and transformation rates are predicated on the amount
of damage existing in DNA at the onset of S phase, but they also
indicate that within the S phase there is a considerable variation
in sensitivity to toxicity and transformation, with early S phase
being most sensitive.
A similar variation in the relative susceptibility of S phase was
also observed by Jones et al. (5, 6) and Tsutsui et al. (7) in studies
with compounds whose action requires that they be incorpo-
rated into DNA during S phase. These similar results with dif-
ferent carcinogenic regimens may suggest the possibility that
specific parts of the genome that replicate early in S phase may
be involved in the S. phase-determined predisposition to
transformation. In our study, sensitivity to transformation ap-
pears to increase at about the time the first cohort of cells pass
the G1-S border and to decrease when the last cohort of cells
has entered S phase. However, further studies with more pre-
cisely synchronized populations of cells will be required to
determine whether sensitivity to transformation in individual
Proc. Natl. Acad. Sci. USA 77 (1980)
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cells is correlated with the initiation of S phase, with the syh-
thesis of a specific gene, or with some other event that occurs
at or sometime after the onset of DNA synthesis.
Although the occurrence of both toxicity and transformation
is maximal when MNNG is applied during the S phase, the
molecular mechanisms underlying these effects seem to differ.
Although synchronized IOT1/2 cells are much more likely to
be inactivated by a toxic event than to be transformed by
MNNG, the ratio of these two effects varies during the cell
cycle. Furthermore, the relationship between dose of MNNG
and each effect is also different: toxicity is directly related to
dose, whereas the logarithm of transformation is directly related
to dose. MNNG-induced toxicity appears to result from inac-
tivation of relatively large amounts of the genome, preventing
DNA from being replicated successfully and preventing cells
from proliferating. Transformation, on the other hand, may
result from more subtle lesions that allow the DNA template
to be replicated, because the expression of a transformed clone
as an altered focus requires repeated proliferation of the ini-
tiated cell.
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